N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide

C20H21F3N6O3S — CID 126508037

IUPACN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide
SMILESCN1CCN(S(=O)(=O)N(Cc2ccc(-c3nnc(C(F)F)o3)cc2F)c2cccnc2)CC1
InChIInChI=1S/C20H21F3N6O3S/c1-27-7-9-28(10-8-27)33(30,31)29(16-3-2-6-24-12-16)13-15-5-4-14(11-17(15)21)19-25-26-20(32-19)18(22)23/h2-6,11-12,18H,7-10,13H2,1H3
InChIKeyTWVMJTFPFLLXIQ-UHFFFAOYSA-N
MW482.49 g/mol
LogP2.71
Rot. Bonds7

About N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide

N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide (PubChem CID 126508037) has the molecular formula C20H21F3N6O3S and a molecular weight of 482.49 g/mol. Its IUPAC name is N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide.

Molecular Properties

Compound NameN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide
PubChem CID126508037
Molecular FormulaC20H21F3N6O3S
Molecular Weight482.49 g/mol
Exact Mass482.13
IUPAC NameN-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide
SMILESCN1CCN(S(=O)(=O)N(Cc2ccc(-c3nnc(C(F)F)o3)cc2F)c2cccnc2)CC1
InChIInChI=1S/C20H21F3N6O3S/c1-27-7-9-28(10-8-27)33(30,31)29(16-3-2-6-24-12-16)13-15-5-4-14(11-17(15)21)19-25-26-20(32-19)18(22)23/h2-6,11-12,18H,7-10,13H2,1H3
InChIKeyTWVMJTFPFLLXIQ-UHFFFAOYSA-N
XLogP2.71
TPSA95.67 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500482.49
LogP ≤ 52.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide?
The IUPAC name of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide (CID 126508037) is N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide.
What is the SMILES notation for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide?
The canonical SMILES for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide is CN1CCN(S(=O)(=O)N(Cc2ccc(-c3nnc(C(F)F)o3)cc2F)c2cccnc2)CC1.
What is the InChIKey of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide?
The InChIKey is TWVMJTFPFLLXIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H21F3N6O3S/c1-27-7-9-28(10-8-27)33(30,31)29(16-3-2-6-24-12-16)13-15-5-4-14(11-17(15)21)19-25-26-20(32-19)18(22)23/h2-6,11-12,18H,7-10,13H2,1H3.
What are the key properties of N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide?
N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide has a molecular weight of 482.49 g/mol, XLogP of 2.71, 7 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-fluorophenyl]methyl]-4-methyl-N-pyridin-3-ylpiperazine-1-sulfonamide is sourced from PubChem (CID 126508037), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).